pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

TAG: Series B

Sep 19, 2023

ReCode Therapeutics Announces Closing of Extension to Series B Financing

Sep 12, 2023

ROME Therapeutics Closes Oversubscribed $72 Million Series B Extension to Support Advancement of Lead Program into Clinical Development for Autoimmune Disease

Aug 23, 2023

Rapport Therapeutics Raises $150 Million in Series B Funding Round and Announces Key Board Appointments to Further Advance Precision Neuromedicine Platform

Aug 21, 2023

Genesis Therapeutics Closes Oversubscribed $200 Million Series B

Aug 17, 2023

Abcuro Announces $155 Million Oversubscribed Series B Financing to Further Advance Autoimmune Pipeline

Jun 28, 2023

Evommune Adds Additional Investment In Series B Financing And Bolsters Leadership Team

Jun 28, 2023

K36 Therapeutics Announces $70 Million Series B Financing to Fund Clinical Proof of Concept of KTX-1001, First-in-class Inhibitor of MMSET for Treatment of Multiple Myeloma Patients with Genetic Translocation (4;14)

Jun 23, 2023

Calidi Biotherapeutics Announces Commitment of $25 Million in Series B Funding to Advance Stem Cell-Based Platforms for the Delivery and Potentiation of Oncolytic Viruses to Treat Cancer

Jun 11, 2023

Eccogene Raises CNY 180 Million in Series B Equity Financing, Propelling its Pipeline of Treatments for Metabolic Diseases

May 16, 2023

Ensoma Closes Series B Extension, Bringing Total Round to $135 Million

Apr 26, 2023

Evommune Closes $50 Million Series B Financing to Advance Broad Pipeline of Therapies to Treat Chronic Inflammatory Diseases

Mar 27, 2023

ArriVent Biopharma Closes $155 Million Oversubscribed Series B Financing

Mar 22, 2023

Cognito Therapeutics Raises $73M Series B to Advance Neurotechnology Platform for Alzheimer’s Disease

Mar 22, 2023

Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing

Mar 9, 2023

QurAlis Closes $88 Million Series B Financing to Advance Precision Medicines for Neurodegenerative Diseases

Mar 7, 2023

LENZ Therapeutics Announces $83.5 Million Series B Financing to Advance its Presbyopia Treatments LNZ100 and LNZ101 and Provides Update on Ongoing Phase 3 Studies

Mar 7, 2023

Noema Pharma Raises CHF 103 Million (USD 112 Million) in Series B Financing Round Led by Forbion and Jeito Capital

Mar 6, 2023

Bicara Therapeutics Announces Oversubscribed $108 Million Series B Financing to Advance Clinical-Stage Pipeline of Dual-Action Biologics to Treat Cancer

Mar 1, 2023

Chroma Medicine Secures $135M in Series B Financing to Advance Breakthrough Epigenetic Editing Technology and Expand Pipeline of Durable Precision Genomic Medicines

Feb 13, 2023

Cerevance Expands Series B Financing with Additional $51 Million 

Feb 6, 2023

IgGenix Announces First Close of $40M Series B Financing to Accelerate Lead Antibody Program in Peanut Allergy

Jan 26, 2023

Grey Wolf Therapeutics Closes Oversubscribed $49 Million Series B Financing to Advance First-of-its-Kind Neoantigen Creation Approaches

Jan 5, 2023

Metagenomi Closes Oversubscribed Series B Financing Totaling $275M to Advance Lead Therapeutic Programs into Clinical Development and Grow Genetic Medicines Pipeline

Jan 5, 2023

Immune-Onc Therapeutics Announces Close of Series B Extension Financing, Bringing Total Round to $131 Million

Dec 15, 2022

Gilgamesh Pharmaceuticals Raises $39 Million Series B to Advance Mental Health Treatments

Dec 14, 2022

STORM Therapeutics announces closing of USD $30M Series B financing

Oct 13, 2022

Odyssey Therapeutics Announces Oversubscribed $168 Million Series B Financing

Oct 11, 2022

Neumora Therapeutics Announces $112 Million Series B Financing

Oct 11, 2022

Metagenomi Announces Opening of Manufacturing Facility for its Next Generation CRISPR Gene-Editing Systems and Therapies

Oct 5, 2022

Valitor Announces the Closing of its Series B Financing and Names Steven Lo as Chief Executive Officer

Sep 22, 2022

Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment of Obesity and Cardio-Metabolic Disorders

Sep 15, 2022

Galvanize Therapeutics Announces Merger to Create the Premier Pulsed Electric Field Therapy Company and Completion of $100 Million Series B Financing USA - English España - español France - Français Deutschland - Deutsch

Sep 14, 2022

SparingVision Raises €75 Million Series B to Continue Building World-Leading Portfolio of Genomic Medicines for Ocular Diseases

Aug 24, 2022

SaNOtize Announces $24 Million in Series B Funding to Advance Its Nitric Oxide-Based Therapeutics, Including Nasal Spray for the Treatment and Prevention of COVID-19

Aug 16, 2022

Orna Therapeutics Raises $221 Million Series B Financing to Advance Circular RNA Platform and Accelerate Programs to the Clinic

Jul 27, 2022

BridGene Biosciences Announces $38.5 Million Series B Financing to Further Develop Its Next Generation Chemoproteomics Platform and First-in-Class Oncology Drugs

Jul 20, 2022

CAMP4 Secures $100 Million Series B Financing to Accelerate Expansion of its Novel Regulatory RNA-Targeting Platform and Advance Lead Programs into the Clinic

Jun 29, 2022

ReCode Therapeutics to Expand Next-Generation Delivery Platform and Diversify Genetic Medicines Pipeline with Oversubscribed Series B Financing Totaling $200M

Jun 8, 2022

Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension

Jun 7, 2022

ImmunOs Therapeutics Raises $74 Million Series B Financing Round

May 31, 2022

Sapience Therapeutics Announces $41 Million Series B Financing to Advance Pipeline of Peptide Therapeutics Targeting Protein-Protein Interactions

May 18, 2022

SwanBio Therapeutics Announces $56 Million Series B Financing to Advance Novel Gene Therapies for Neurological Conditions

May 17, 2022

Remix Therapeutics Closes $70 Million Series B Financing

May 10, 2022

MOMA Therapeutics Announces $150 Million Series B Financing

May 9, 2022

Aspen Neuroscience Announces $147.5 Million Series B Financing, Led by GV, LYFE Capital and Revelation Partners

May 5, 2022

Curebase Secures $40 Million in Series B Funding

Apr 28, 2022

OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases

Apr 27, 2022

Ashvattha Therapeutics Announces $69 Million in Series B Financing and up to $45M Exclusive License Agreement with Huadong to Advance Hydroxyl Dendrimer-Based Precision Medicines

Apr 12, 2022

SV Health Investors Joins Prilenia Series B as the Company Prepares for ALS and HD Data Readouts in the Next 12 Months

Apr 4, 2022

Adaptive Phage Therapeutics Extends Series B to $61 million with Addition of The AMR Action Fund

Mar 31, 2022

Incyclix Bio Announces $30 Million Series B Financing Led by Boxer Capital

Mar 29, 2022

Angiocrine Bioscience Announces First Patient Dosed in Pivotal Phase 3 Clinical Trial of AB-205 in Patients with Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation (E-CELERATE) and Completion of Series B Financing

Mar 28, 2022

Spine BioPharma Completes Series B Financing

Mar 22, 2022

Spotlight Therapeutics Raises $36.5 Million Series B to Advance a Pipeline of Cell-Targeted In Vivo CRISPR Gene Editing Biologics

Mar 8, 2022

Osteal Therapeutics Closes an Oversubscribed $30 Million Series B Financing to Advance Platform Therapy for Treatment of Musculoskeletal Infection

Mar 3, 2022

InxMed Raised $50 million in Series B Financing to Advance Innovative Therapies to Drug-resistance Cancers

Mar 2, 2022

Epsilogen Announces Completion of Oversubscribed £30.75 Million ($41.20 Million) Series B Financing

Feb 16, 2022

Electra Therapeutics Announces $84 Million Series B Financing and Unveils Its Novel SIRP‑Targeted Therapies for Immunological Diseases and Cancer

Feb 16, 2022

Memo Therapeutics AG Closes Series B Financing at CHF37 Million Following Oversubscribed CHF23 Million Extension

Feb 10, 2022

Arkuda Therapeutics Raises $64 Million Series B Financing to Advance Pipeline of Programs Targeting Lysosomal Biology to Treat Neurodegenerative Diseases

Feb 7, 2022

Endeavor BioMedicines Closes $101M Series B Financing to Advance Clinical-Stage Precision Medicine Pipeline

Jan 25, 2022

Metagenomi Closes Oversubscribed $175M Series B Financing to Advance Therapeutic Pipeline and Expand Novel Gene Editing Platform

Jan 7, 2022

AN2 Therapeutics Closed $80 Million Series B Financing to Advance Novel Nontuberculous Mycobacterial Lung Disease Program

Jan 6, 2022

Eikon Therapeutics Announces $517.8 Million Series B Raise and Expansion of Executive Leadership Team

Jan 6, 2022

RD Fund Announces Series B Financing Behind SalioGen Therapeutics

Jan 5, 2022

Korro Bio Completes $116M Series B Financing to Expand the Frontier of Genetic Medicine Through Its Pipeline of RNA Editing Programs

Jan 5, 2022

SalioGen Therapeutics Closes $115 Million Oversubscribed Series B Financing to Advance Gene Coding™ – A New Category of Genetic Medicine

Dec 16, 2021

Verge Genomics Secures $98 Million in New Financing

Dec 16, 2021

Anaveon to raise CHF 110 million in oversubscribed Series B financing

Dec 8, 2021

OncoMyx Closes $50 Million Series B to Advance a Novel Immuno-Oncology Platform that Delivers Multiple Cancer-Killing Payloads

Nov 29, 2021

Quell Therapeutics Raises $156 million in Oversubscribed Series B Financing to Advance its Pioneering Multi-Modular Engineered T Regulatory (Treg) Cell Therapy Pipeline and Platform

Nov 29, 2021

Jeito Capital co-leads $156 million oversubscribed Series B financing in Quell Therapeutics

Nov 18, 2021

Treadwell Therapeutics Announces The Closing of a $91 Million Series B Financing

Nov 16, 2021

ACELYRIN, INC. Closes $250 Million Series B Financing and Announces Licensing of Izokibep, a Late-Stage IL-17A Inhibitor to Treat Inflammatory Diseases

Nov 12, 2021

Ankyra Therapeutics Announces $45 Million Series B Financing and Appoints Howard L. Kaufman M.D. as Chief Medical Officer

Nov 9, 2021

Arbor Biotechnologies Closes $215 Million Oversubscribed Series B Financing to Advance Next-Generation Precision Editing Therapeutics

Nov 9, 2021

OcuTerra Raises $35 Million Series B Financing

Nov 4, 2021

PlateletBio Completes $75.5M Series B Financing

Nov 3, 2021

Prilenia Closes Oversubscribed $43 Million in Series B Financing Round

Oct 28, 2021

4BIO Capital Joins Investor Syndicate in CARISMA Therapeutics’ Second Closing of $59 Million Series B Round

Oct 25, 2021

Cedilla Therapeutics Completes $82.6M Series B Financing

Oct 22, 2021

Click Therapeutics Completes $52 Million Series B Financing Co-Led by H.I.G. BioHealth Partners and Accelmed Partners

Oct 21, 2021

ReCode Therapeutics Raises Oversubscribed Series B Financing Round of $80 Million

Oct 12, 2021

CinCor Pharma Raises $143 Million in Series B Financing

Sep 29, 2021

Expansion Therapeutics Raises $80 Million Series B Financing to Treat Neurodegenerative Diseases

Sep 16, 2021

Amolyt Pharma Announces $80 Million Series B Financing led by Sectoral Asset Management and Andera Partners

Sep 14, 2021

ROME Therapeutics Secures $77 Million in Series B Financing to Advance Repeatome-derived Pipeline for Cancer and Autoimmune Diseases and Expand Repeatomics Platform

Sep 14, 2021

Vanqua Bio Launches with $85 Million Series B Financing and a Mission to Vanquish Neurodegenerative Diseases

Sep 13, 2021

TreeFrog Therapeutics Secures $75m In Series B Financing To Advance A Pipeline Of Stem Cell-Derived Cell Therapies And Deploy Proprietary C-Stem™ Technology In The USA and Japan

Sep 9, 2021

Obsidian Therapeutics Announces Closing of $115 Million Series B Financing

Sep 9, 2021

LEXEO Therapeutics Closes $100 Million Series B Financing to Advance Clinical Stage Gene Therapy Pipeline and Enhance Preclinical Footprint

Sep 8, 2021

Alamar Biosciences Completes $80M Series B Fundraising to Bring Unprecedented Performance to the Proteomics Market

Sep 8, 2021

Attralus Closes $116 Million Series B Financing

Sep 2, 2021

Disc Medicine Announces $90 Million Series B Financing to Advance Portfolio of Clinical-Stage Therapies for Hematologic Diseases

Sep 1, 2021

Asher Bio Closes $108 Million Series B Financing

Aug 27, 2021

Lynk Pharmaceuticals announced the completion of Series B financing of $50 million

Aug 26, 2021

Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders

Aug 25, 2021

Cardior Raises €64M Series B to Advance Clinical Pipeline of RNA Therapeutics to Treat Cardiac Disease

Aug 18, 2021

Jnana Therapeutics Closes $50 Million Series B Financing to Advance Lead PKU Program and Small Molecule Pipeline Based on Next Gen Chemoproteomic Platform

Aug 18, 2021

Vigil Neuroscience Completes $90 million Series B Financing to Advance a Pipeline of Microglia-targeted Medicines to Treat Rare and Common Neurodegenerative Diseases

Aug 18, 2021

Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases

Aug 18, 2021

Ranok Therapeutics Secures $40 Million Series B Financing to Advance its Innovative Targeted Protein Degradation Pipeline

Aug 10, 2021

Sydnexis Secures $45 Million Series B Financing Led by Visionary Ventures and Blue Stem Capital

Aug 4, 2021

Sonoma Biotherapeutics Raises $265 Million in an Oversubscribed Series B Financing to Translate the Promise of Cell Therapy into Curative Medicines for Autoimmune and Other Inflammatory Diseases

Aug 4, 2021

Eyevensys Raises $12M in a Series B Plus Funding Round

Aug 2, 2021

T-knife Therapeutics Announces $110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies

Jul 22, 2021

Anocca Raises $47m in a Series B Financing to Advance Its Industrialised Approach to TCR-T Cellular Immunotherapy

Jul 21, 2021

ReForm Biologics Announces Corporate Reorganization

Jul 21, 2021

eureKARE invests in Coave Therapeutics as part of its €33 million Series B round

Jul 19, 2021

Frontier Medicines Raises $88.5 Million Series B Financing to Advance Precision Oncology and Targeted Protein Degradation Pipeline

Jul 15, 2021

Shape Therapeutics Secures $112 Million in Series B Financing to Advance Breakthrough RNA Technology Platforms to Democratize Gene Therapy

Jul 15, 2021

Wugen Raises $172 Million to Advance Clinical Stage Memory NK Cell Platform, Progress Best-In-Class AML Program, and Initiate Multiple Solid Tumor Trials

Jul 14, 2021

Kriya Therapeutics Completes $100 Million Series B Financing to Advance Its Fully Integrated Platform for Designing, Developing and Manufacturing Transformative Gene Therapies

Jun 29, 2021

Adaptive Phage Therapeutics Expands Board Following Series B Financing Led by Deerfield Management

Jun 23, 2021

Orum Therapeutics Closes $84 Million Series B Financing to Advance Novel Targeted Protein Degrader Payloads into Clinical Trials for Cancer

Jun 17, 2021

OncoNano Medicine Raises ~$50 Million in Series B Financing

Jun 15, 2021

Umoja Biopharma Closes an Oversubscribed $210 Million Series B Financing to Expand Integrated Immunotherapy Platforms and Advance Programs to the Clinic

Jun 10, 2021

Senda Biosciences Announces Closing of $98 Million Series B Financing

Jun 10, 2021

Synthekine Announces $107.5 Million Oversubscribed Series B Financing to Support Lead Programs to Clinical Proof of Concept, Advance Preclinical Programs and Platform

Jun 10, 2021

Bright Peak Therapeutics Announces $107 Million Series B Financing and Expanded Board of Directors

May 25, 2021

Phanes Therapeutics Announces $40 million Series B Financing

May 19, 2021

HiberCell Closes $67.4 Million Series B Financing and Secures $30 Million Debt Facility from Hercules Capital

May 13, 2021

SpliSense Secures $28.5 Million in Series B Financing USA - English USA - English

May 13, 2021

SpliSense Secures $28.5 Million in Series B Financing

May 11, 2021

Adaptive Phage Therapeutics Announces $40.75 Million Series B Financing

May 3, 2021

Affinia Therapeutics Closes $110 Million Series B Financing

Apr 29, 2021

Chardan Acts as Exclusive Placement Agent in Forge Biologics' $120 Million Series B Financing

Apr 29, 2021

Forge Biologics Announces Closing of $120 Million Series B Financing

Apr 28, 2021

Boundless Bio Raises Oversubscribed $105 Million Series B Financing to Advance Next-Generation Precision Oncology Therapies Directed Against Extrachromosomal DNA (ecDNA)

Apr 21, 2021

EdiGene Raises Approximately USD 62 Million in Series B Plus Financing and Expands Operation Locations to Advance and Scale Up Clinical Translation of Gene Editing Technologies

Apr 20, 2021

Janux Therapeutics Closes $125 Million Series B Financing to Advance Next Generation T Cell Engager Immunotherapies into Clinical Trials

Apr 12, 2021

Antios Therapeutics Raises $96 Million in a Series B Financing

Apr 8, 2021

Ventus Therapeutics Closes $100 Million Series B Financing

Mar 31, 2021

Scribe Therapeutics Raises $100M Series B Financing to Further Develop “CRISPR by Design” Platform and Pipeline of Breakthrough Genetic Medicines

Mar 31, 2021

Entrada Therapeutics Announces Closing of $116 Million Series B Financing

Mar 30, 2021

Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics

Mar 30, 2021

AffaMed Therapeutics Announces Completion of over US$170 Million Series B Financing Led by Lake Bleu Capital to Further Development of Ophthalmic and Neuroscience Pipeline

Mar 25, 2021

Apnimed Closes Series B Financing to Advance Once-Daily Oral Medication for Obstructive Sleep Apnea (OSA)

Mar 24, 2021

Step Pharma Raises EUR35 Million in Series B Financing to Advance First in Class CTPS1 inhibitor into the Clinic in T Cell Malignancies

Mar 23, 2021

XtalPi Invests in Novel Target Discovery Biotech PhoreMost in Oversubscribed Series B Financing

Mar 16, 2021

StrideBio Announces Closing of $81.5M Series B Financing

Mar 15, 2021

Graphite Bio Secures $150 Million Series B Financing to Advance Pipeline of Next-Generation Gene Editing Therapies

Mar 10, 2021

AgomAb Therapeutics Raises $74 Million Series B to Advance Regenerative Pathway Modulators

Mar 10, 2021

Cybrexa Therapeutics Closes $25 Million Series B Financing

Mar 4, 2021

Amunix Raises $117 Million Series B Financing to Fund its Oncology Pipeline

Mar 1, 2021

CARISMA Therapeutics Completes Series B Financing Totaling $59 Million

Feb 26, 2021

Artiva Biotherapeutics Raises $120 Million in Series B Financing to Advance Pipeline of Allogeneic NK Cell Therapies

Feb 25, 2021

Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target

Feb 25, 2021

Cullgen Closes $50 Million Series B Investment to Advance Targeted Protein Degraders and Novel E3 Ligands Platform

Feb 24, 2021

YishengBio Raises $130 Million in Series B Funding to Accelerate Pipeline Development and Commercialization USA - English Brazil - Português USA - English

Feb 24, 2021

YishengBio Raises $130 Million in Series B Funding to Accelerate Pipeline Development and Commercialization

Feb 18, 2021

Sciwind Biosciences Secures US$37 Million Series B Financing

Feb 17, 2021

Elicio Therapeutics Secures a Total of $73 Million in Series B Financing

Feb 16, 2021

Iterion Therapeutics Secures $17 Million to Advance Development of Tegavivint in Multiple Tumor Settings

Feb 9, 2021

Neurophth Closes RMB 400 Million Series B Financing

Jan 19, 2021

Verve Therapeutics Secures $94 Million in Series B Financing to Advance Pipeline of Gene Editing Medicines for Cardiovascular Disease

Jan 13, 2021

IO Biotech Completes Oversubscribed EUR 127 Million Series B Financing to Accelerate Clinical Programs in Oncology

Jan 13, 2021

Novo Seeds' Portfolio Company, IO Biotech, Completes Oversubscribed EUR 127M Series B Financing to Accelerate Clinical Programs in Oncology

Jan 12, 2021

Tessera Therapeutics Attracts Over $230M in Series B Financing to Advance ‘Gene Writing’ – A New Category in Genetic Medicine

Jan 8, 2021

VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China

Jan 7, 2021

CARISMA Therapeutics Completes Series B Funding for $47 Million to Advance Development of Novel CAR-Macrophage Immunotherapies

Jan 7, 2021

Werewolf Therapeutics Completes $72 Million Series B Financing to Advance a Novel Class of Cancer Biotherapeutics to the Clinic

Jan 7, 2021

LifeMine Therapeutics Announces $50 Million Series B Financing

Jan 7, 2021

Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing

Jan 6, 2021

Leaps by Bayer Leads USD 105 Million Series B Financing in Senti Bio to Develop Next-Generation Cell and Gene Therapies Using Advanced Gene Circuit Technology Platform

Jan 5, 2021

Immuneering Completes Oversubscribed $62 Million Series B Financing

Dec 21, 2020

Peptilogics Closes $35.4 Million Series B Financing to Further Advance Proprietary Computational Peptide Drug Design and Discovery Platform

Dec 15, 2020

DLA Piper advises Locanabio in its US$100 million Series B financing

Dec 14, 2020

Locanabio Announces $100 Million Series B Financing to Advance Portfolio of Novel RNA-Targeted Gene Therapies for Neurodegenerative, Neuromuscular and Retinal Diseases

Dec 8, 2020

RayzeBio Completes $105M Series B Financing to Advance Targeted Radiopharmaceuticals for Cancer

Dec 1, 2020

MaaT Pharma Announces Series B Extension and Final Closing with Total of €25 Million ($29.5 Million)

Nov 18, 2020

Elevation Oncology Announces $65M Series B Financing and Promotion of Founder Shawn M. Leland to Chief Executive Officer

Nov 12, 2020

Taysha Gene Therapies Reports Third Quarter 2020 Financial Results and Provides Business Update

Nov 10, 2020

Adagio Therapeutics Raises $80M Series B Round to Further Advance Best-In-Class Antibodies for Coronavirus Treatment and Prevention

Nov 6, 2020

Memo Therapeutics AG Raises CHF 14 Million in a Series B Financing Round

Oct 27, 2020

Prokarium Closes $21M Series B Financing Round and Strengthens Board

Oct 15, 2020

Leaps by Bayer Leads USD 17 Million Series B Financing in Biotech Company Azitra

Oct 13, 2020

Cedilla Therapeutics Announces $57.6 Million Series B Financing

Oct 13, 2020

EdiGene Raises Approximately USD 67 Million in Series B Financing to Advance Gene Editing Based Programs into Clinical Stage

Oct 6, 2020

Talaris Therapeutics Closes $115 Million Series B Financing

Oct 6, 2020

A2 Biotherapeutics Closes $71.5M Series B To Begin Clinical Development Of Its Potentially Transformative Selective Tumor Cell Therapeutics

Oct 6, 2020

A2 Biotherapeutics Closes $71.5M Series B to Begin Clinical Development of Its Potentially Transformative Selective Tumor Cell Therapeutics

Sep 28, 2020

ILIAS Biologics Closes $20.6 Million Series B Financing

Sep 24, 2020

Monte Rosa Therapeutics Announces $96 Million Series B Financing to Advance Small Molecule-based Protein Degradation Platform

Sep 23, 2020

ImmVira Announces US$10 million Strategic Series B Plus Financing with SIIC Capital

Sep 23, 2020

Nutcracker Therapeutics Announces $60 Million Series B Financing to Advance mRNA Therapeutics Produced on Transformational Biochip-Based ACORN Platform

Sep 17, 2020

Palleon Pharmaceuticals Raises $100 million Series B to Develop Drugs Targeting Glycan-Mediated Immune Regulation to Treat Cancer and Inflammatory Diseases

Sep 15, 2020

ImCheck Announces Investment by BB Pureos Bioventures to Close Series B Fundraising with Total of €54 million ($64 million)

Sep 14, 2020

Escient Pharmaceuticals Raises $77.5 Million Series B Round and Initiates a Phase 1/1b Clinical Trial of EP547, a MRGPR-targeted Therapy to Treat Cholestatic and Uremic Pruritus

Sep 10, 2020

Casma Therapeutics Announces $50 Million Series B Financing

Sep 9, 2020

OncoImmune, Inc. Raises $56 Million Series B Financing for Novel Cancer and COVID-19 Therapeutics

Sep 8, 2020

Inversago Pharma Closes US$35M Series B Financing Round and Expands Board of Directors

Sep 1, 2020

Lumen Bioscience Raises $16M Series B Financing to Accelerate Clinical Development of Accessible Biologic Drugs

Aug 31, 2020

Embera NeuroTherapeutics Announces First Subject Dosed in Phase 2 Study of EMB-001 in Cocaine Use Disorder

Aug 11, 2020

Atomwise Raises $123 Million in Series B Financing Co-Led by B Capital Group and Sanabil

Aug 5, 2020

Taysha Gene Therapies Announces Oversubscribed $95 Million Series B Financing to Bolster Initial Clinical Studies in GM2 Gangliosidosis and Advance Pipeline of Gene Therapies for Monogenic CNS Disease in Both Rare and Large Patient Populations

Jul 21, 2020

Gain Therapeutics, Inc. Announces Close of $10 Million Series B Financing

Jul 21, 2020

Cerevance Expands Series B Financing to $65 Million

Jul 17, 2020

SAB Biotherapeutics Closes Series B Funding

Jul 7, 2020

Vor Biopharma Closes $110 Million Series B Financing

Jul 1, 2020

Amylyx Pharmaceuticals Raises $30 Million in Series B Funding

Jun 30, 2020

Goldfinch Bio Secures $100 Million in Series B Financing

Jun 24, 2020

Cyclica Raises CAD$23 Million in a Series B Financing to Create the Biotech Pipeline of the Future

Jun 16, 2020

eTheRNA Raises EUR 34 Million in Series B Financing to Accelerate Multiple mRNA Therapeutic Development Programs Through to Clinical Proof of Concept

Jun 15, 2020

ImmVira Raises $58M in Series B financing

Jun 9, 2020

Autobahn Therapeutics Launches with $76 Million Series B Financing to Develop Next Generation Therapies for CNS Disorders

Jun 4, 2020

Cullinan Oncology Completes $98.5 Million Series B Financing

Jun 4, 2020

Athira Pharma Closes $85 Million Series B Financing

Jun 3, 2020

NodThera Announces Close of $55 Million Series B Financing

May 27, 2020

Avalyn Pharma Secures $35.5 Million Series B Financing, Broadens Development Portfolio

May 27, 2020

AbCellera Closes $105 Million Series B Financing to Further Advance World-Leading Antibody Drug Discovery Platform

May 26, 2020

insitro Announces $143 Million Raised in Series B Financing

May 21, 2020

HotSpot Therapeutics Completes $65 Million Series B Financing to Advance Pipeline of Novel Allosteric Medicines

May 19, 2020

Rallybio Completes $145 Million Series B Financing and Announces Plans to Advance Lead Product Candidate into the Clinic in 2H 2020

May 10, 2020

Hummingbird Bioscience Closes US$25 Million Investment With Series B Extension USA - English USA - English

May 10, 2020

Hummingbird Bioscience Closes US$25 Million Investment With Series B Extension USA - English India - English

May 9, 2020

Tango Therapeutics Raises $60 Million Series B Financing and Strengthens Executive Team

May 1, 2020

Pandion Therapeutics Announces Close of $80 Million Series B Financing

Apr 29, 2020

Cadent Therapeutics Closes $15 Million Final Equity Tranche of Series B Financing

Apr 23, 2020

Accent Therapeutics Announces $63 Million Series B Financing to Advance Novel, Precision Cancer Therapies Targeting RNA-Modifying Proteins

Apr 23, 2020

Affinivax Announces $120 Million Series B Financing to Advance Pipeline of Novel MAPS Vaccines and Immunotherapies

Apr 14, 2020

Cerevance Closes $45 Million Series B Financing

Mar 30, 2020

ElevateBio Closes $170 Million Series B Financing

Mar 24, 2020

IASO Biotherapeutics Raises $60 Million in Series B Financing Led by GL Ventures to Advance Cell Therapies for Cancer Care

Mar 17, 2020

Sigilon Therapeutics Announces $80.3 Million Series B Financing to Advance Shielded Living Therapeutics™ to the Clinic

Mar 17, 2020

CORRECTING and REPLACING Circle Pharma Raises $45 Million in Series B Financing

Mar 11, 2020

Silverback Therapeutics Raises $78.5 Million in Oversubscribed Series B Financing

Mar 3, 2020

Akouos Closes $105 Million Series B Financing

Mar 2, 2020

Akrevia Therapeutics Rebrands as Xilio Therapeutics and Announces $100.5 Million Series B Financing

Feb 11, 2020

Inotrem Expands Series B Financing to €58 Million With a Mix of Equity and Debt, Adding New Investors Fountain Healthcare Partners, Kreos and Bpifrance

Feb 5, 2020

MaaT Pharma Announces €18 Million Series B Financing Round to Support Further Clinical Development of Microbiome Biotherapeutics

Jan 13, 2020

Codagenix Raises $20 Million in Series B Funding for Continued Development of RSV, Influenza and Oncolytic Virus Products

Jan 10, 2020

Aligos Therapeutics Closes $125M Series B Financing

Jan 8, 2020

NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA study in NASH and to Advance Two Additional SEFAs into the Clinic

Jan 8, 2020

Tarsus Pharmaceuticals Raises $60 Million in Series B Financing

Jan 8, 2020

Transcenta Holding Secures $100 Million Series B Plus Financing

Jan 7, 2020

Cerebral Therapeutics Completes $35 Million Series B Financing

Dec 20, 2019

Oncorus Appoints Mary Kay Fenton to its Board of Directors

Dec 19, 2019

Kinnate Biopharma Closes $74.5M Series B Financing

Dec 19, 2019

Embera NeuroTherapeutics Completes Series B Financing and Receives Grants to Advance EMB-001 into Phase 2 Clinical Studies in Cocaine Use Disorder and Smoking Cessation

Dec 18, 2019

Pipeline Therapeutics Completes $30 Million Series B Financing

Dec 17, 2019

Cellestia Biotech AG successfully closes Series B financing round, raising a total of CHF 20 million

Dec 4, 2019

ImCheck Raises $53 Million Series B to Advance Clinical Pipeline of Novel Gamma Delta T-Cell-Focused Antibodies for Cancer and Autoimmune Diseases

Dec 4, 2019

Hummingbird Bioscience Raises US$19 Million in Series B Financing USA - English USA - English

Dec 4, 2019

Hummingbird Bioscience Raises US$19 Million in Series B Financing USA - English India - English

Nov 27, 2019

Clover Biopharmaceuticals Completes $43 Million Series B Financing

Nov 22, 2019

Heartseed Raises $26M in Series B Funding to Accelerate Development of iPSC-derived Regenerative Medicine for Heart Failure

Nov 7, 2019

eGenesis Announces $100 Million Series B Financing

Nov 7, 2019

Bayer invests $50 Million in eGenesis Series B financing round

Nov 6, 2019

Acticor Biotech Raises €7M In Addition to Its Series B Financing, Now Completed At €22,3M

Oct 31, 2019

Tmunity Raises $75 Million in Series B Financing to Advance Next-Generation T-Cell Therapies

Oct 16, 2019

Healx Secures $56M in Series B Financing, Launches Global Accelerator Programme for Rare Diseases

Oct 3, 2019

Tenaya Therapeutics Closes $92 Million Series B Financing

Oct 3, 2019

Arcellx Raises $85 Million in a Series B Financing to Advance its Intelligent Cell Therapy Platform

Oct 2, 2019

Adicet Bio Raises $80M in Series B Financing

Sep 18, 2019

Versantis Closes CHF 16M Series B Financing Round to Advance Clinical Development of Novel Therapeutics for Liver Diseases

Sep 17, 2019

Linnaeus Therapeutics Closes $12 Million Series B Financing

Sep 12, 2019

Inotrem Announces €39 Million Series B Financing to Develop First-In-Class Immunology Therapeutics

Sep 10, 2019

Pharvaris Announces $66 Million Series B Financing to Advance the Clinical Development of an Oral Therapy for Hereditary Angioedema

Sep 10, 2019

Numerated Raises $15M to Make All Banks Growth Banks

Sep 4, 2019

Repare Therapeutics Announces US$82.5 Million Series B Financing

Sep 4, 2019

Nkarta Therapeutics Raises $114 Million in Series B Financing to Advance Multiple Programs into Clinical Trials

Sep 4, 2019

Passage Bio Closes $110 Million Series B Financing

Aug 21, 2019

Oncorus Announces $79.5 Million Series B Financing Co-Led by Cowen Healthcare Investments and Perceptive Advisors

Aug 19, 2019

Juvenescence Closes $100 Million Series B Round, Plans Follow on and Incremental Investments in Longevity Drug Development

Aug 13, 2019

Landos Biopharma Completes $60 Million Series B Financing

Jul 17, 2019

Orum Therapeutics Announces $30 Million Series B Financing to Advance Cell-Penetrating, Cell-Specific Antibody Technology for Novel Therapeutics

Jun 20, 2019

Axial Biotherapeutics Announces $10M Investment from Taiho Ventures to Access Axial’s Expertise in the Gut-Brain Axis

Jun 17, 2019

Viela Bio Closes $75 Million Series B Financing

Jun 13, 2019

BlackThorn Therapeutics Closes $76 Million Series B to Advance Targeted Therapeutics for Mental Health

Jun 10, 2019

Oncologie Closes an $80M Series B Financing for Clinical-Stage Pipeline

Jun 5, 2019

EpimAb Biotherapeutics Raises $74M in Series B Financing

May 30, 2019

Whole Biome Secures $35 Million in Series B Financing for Expansion of its Microbiome Discovery Platform and Commercialization of its First Product

May 29, 2019

Pi Therapeutics Announces $19.7 Million Series B Financing USA - English USA - English

May 28, 2019

Ayala Pharmaceuticals Raises $30 Million in Series B Financing

May 21, 2019

Concentric Analgesics Raises $76 Million in Series B Financing

May 1, 2019

Karuna Completes $80 Million Series B Financing

Apr 30, 2019

Vividion Therapeutics Announces Oversubscribed $82 Million Series B Financing

Apr 30, 2019

Bexion Pharmaceuticals Increases Series B to $25MM

Apr 18, 2019

Arrakis Therapeutics Announces $75 Million Series B Financing to Advance a New Class of Small-Molecule Medicines Targeting RNA

Apr 10, 2019

EdiGENE Raises $15 Million in Series B Funding

Apr 2, 2019

Fusion Pharmaceuticals Raises $105 Million in Oversubscribed Series B Financing

Apr 1, 2019

SpringWorks Therapeutics Completes $125 Million Series B Financing

Mar 27, 2019

Prevail Therapeutics Secures $50 Million in Series B Financing to Advance Pipeline of Gene Therapies for Neurodegenerative Diseases

Mar 25, 2019

Arch Oncology Raises $50 Million Series B Financing

Mar 21, 2019

Imago BioSciences Announces $40 Million Series B Financing Led by Omega Funds

Mar 18, 2019

Imara Closes a $63MM Series B Cross-Over Financing

Mar 18, 2019

Karuna Announces $68 Million Series B Financing

Mar 14, 2019

Surrozen Raises $50 Million in Series B Financing to Advance Regenerative Antibody Platforms and Liver Disease Candidates

Mar 6, 2019

Beam Therapeutics Secures $135 Million in Series B Financing to Advance Base Editing Platform and Expand Pipeline of Precision Genetic Medicines

Feb 27, 2019

Axial Biotherapeutics Raises $25 Million in Series B Financing

Feb 25, 2019

Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies

Feb 5, 2019

Bolt Biotherapeutics Completes $54 Million Series B Financing

Jan 29, 2019

Lyndra Therapeutics Raises $55 Million in Series B Financing

Jan 23, 2019

Attune Pharmaceuticals Announces $23M Series B Financing to Advance ATN-249 for the Treatment of HAE

Jan 16, 2019

Juvenescence Closes First Tranche of Series B Enabling Further Growth and Development

Jan 10, 2019

Black Diamond Therapeutics Closes $85 Million Series B Financing

Jan 8, 2019

Biond Biologics Announces $17 Million Series B Financing

Jan 7, 2019

Frequency Therapeutics Completes $42 Million Series B Financing

Jan 7, 2019

Quark Venture Inc. and GF Securities Participate in Keros Therapeutics’ $23 million Series B Financing for Development of Therapies to Treat Debilitating Neuromuscular Diseases

Jan 7, 2019

Apollomics, Inc. (previously CBT Pharmaceuticals, Inc.) Raises $100 Million in Series B Financing

Jan 4, 2019

Oculis Raises CHF15.5 Million in an Extension of its Series B Financing Round - Total Raised CHF35.5 Million

Jan 1, 2019

Antengene Corporation Raises $120 Million in Series B Financing

Dec 5, 2018

Kallyope Inc. Announces $21 Million Expansion of Series B Financing

Nov 19, 2018

Inflazome Completes €40m ($46m) Series B Financing to Develop NLRP3 Inflammasome Inhibitors to Clinical Proof-of-Concept

Nov 19, 2018

Forbion Leads €40m Series B Financing in Inflazome to Develop NLRP3 Inflammasome Inhibitors to Clinical Proof-of-Concept

Nov 15, 2018

Cadent Therapeutics Secures $40 Million Series B Financing to Advance Pipeline of Novel Therapies for Movement and Cognitive Disorders

Nov 13, 2018

Kymera Therapeutics Announces $65 Million Series B Financing to Advance Pipeline of Targeted Protein Degraders in Oncology and Immunology

Nov 2, 2018

Intensity Therapeutics Raises $6.5 Million in Series B Financing

Oct 30, 2018

Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancer

Oct 23, 2018

Stoke Therapeutics Announces $90 Million Series B Financing to Advance Novel Oligonucleotide Medicines

Oct 17, 2018

Acticor Biotech Raises €15.3M In a Series B Financing

Oct 16, 2018

Velicept Therapeutics Raises an Additional $15 Million in Series B Round, Initiates Phase 2b Study Evaluating Once Daily Dosing of Solabegron in Patients with Overactive Bladder (OAB) and Receives Issuance of Additional U.S. Patent

Sep 26, 2018

Lyra Therapeutics Announces $29.5 Million Series B Financing to Advance Innovative Therapeutics for Ear, Nose and Throat Diseases

Sep 25, 2018

Morphic Therapeutic Announces $80 Million Financing to Advance Next-Generation Oral Integrin Therapeutics Through Clinical Proof of Concept

Sep 18, 2018

Immune-Onc Therapeutics Announces Key Executive Appointments and Series B Funding

Sep 11, 2018

OncoResponse Raises $40 Million in Series B Financing

Sep 5, 2018

4D Molecular Therapeutics Raises $90 Million Series B Financing

Sep 5, 2018

Fulcrum Therapeutics Announces $80 Million Series B Financing

Sep 3, 2018

Evox Therapeutics Completes £35.5 Million Series B Financing

Aug 26, 2018

Harbour BioMed Raises $85 Million in Series B Financing to Accelerate Its Innovative Pipeline

Aug 10, 2018

Artios Pharma Announces $84 Million (£65 Million) Series B Financing

Aug 8, 2018

Apexigen Raises $73 Million In Series B And Series C Financings

Aug 1, 2018

ReViral Announces US$55 Million Series B Fundraising to Advance RSV Clinical Studies

Jul 16, 2018

Pliant Therapeutics Raises $62 Million in Series B Financing to Advance Therapies for Fibrotic Diseases

Jul 11, 2018

Nohla Therapeutics Announces Second Closing of $56 Million Series B Financing

Jul 5, 2018

Adlai Nortye Raises $53M in Series B USA - English España - español France - Français Deutschland - Deutsch

Jul 5, 2018

Adlai Nortye Raises $53M in Series B Deutschland - Deutsch France - Français España - español USA - English USA - English

Jun 26, 2018

Precision BioSciences Raises $110M to Advance ARCUS Genome Editing Programs

Jun 20, 2018

iTeos Therapeutics Completes $75 Million Series B Financing

Jun 18, 2018

WindMIL Therapeutics Announces $32.5 Million in Series B Financing

Jun 11, 2018

AIVITA Biomedical Raises $15M USD in Series B Financing

Jun 5, 2018

Orasis Pharmaceuticals Closes $13 Million Series B Financing

Jun 4, 2018

ENYO Pharma Raises €40 Million in Series B Fundraising

Jun 1, 2018

Xynomic Pharma Completes Series B Crossover Financing, Starts Four Pivotal Trials in Renal Cell Carcinoma (RCC) and Lymphoma, and Opens a R&D Center

May 31, 2018

Cortexyme Completes $76 Million Series B Financing and Provides Update on Clinical Development Progress

May 30, 2018

Crescendo Biologics Ltd. Raises $70 Million (€57 Million) in Series B Financing

May 28, 2018

HitGen Announces Completion of RMB 250 Million Series B Fund Raising

May 25, 2018

Corvidia Therapeutics Secures $60 Million in Series B Funding to Accelerate Clinical Work

May 24, 2018

REVOLUTION Medicines Raises $56 Million Series B Financing

May 16, 2018

FogPharma Secures $66 Million Series B Financing

May 16, 2018

EIP Pharma Secures $20.5 Million in Series B Financing

May 16, 2018

HiFiBiO Therapeutics Secures $37.5 Million Series B Financing to Accelerate Pipeline of Novel Antibody Drugs to Treat Cancer and Autoimmune Disorders

May 15, 2018

Nohla Therapeutics Announces Closing of $45 Million Series B Financing

May 9, 2018

BioClin Therapeutics, Inc., Completes $50 Million Series B Financing with Addition of New Investors

Apr 18, 2018

Tetherex Pharmaceuticals, Inc. Completes $50M Series B Financing

Apr 18, 2018

Grid Therapeutics Closes Series B Financing

Mar 28, 2018

Tempest Therapeutics Closes $70 Million Series B Financing

Mar 15, 2018

IDEAYA Biosciences Raises $94 Million Crossover Series B Financing

Mar 13, 2018

Forbion Leads $19 Million Series B Financing of Escalier Biosciences to Advance its Topical and Systemic RORγt Therapies for Psoriasis and other Autoimmune Diseases

Mar 1, 2018

Finch Therapeutics Group Raises $36 Million in Series B Financing

Feb 27, 2018

Generation Bio Announces $100 Million Series B Financing to Advance GeneWave™ Platform for Re-Dosable Gene Therapy

Feb 22, 2018

Kallyope Inc. Announces $66M Series B Financing to Advance Programs Targeting the Gut-Brain Axis

Jan 23, 2018

AI Biotech XtalPi Closes Series B Round Funding from Sequoia China, Google, and Tencent

Jan 17, 2018

Carmot Therapeutics Announces Close of Series B Financing

Jan 4, 2018

Oculis Raises CHF20 Million in a Series B Financing Round to Advance Breakthrough Treatments for Ophthalmic Diseases

Jan 2, 2018

PEAR Therapeutics Completes $50 Million Series B Financing

Dec 21, 2017

TARIS Biomedical® Announces $25M Series B Financing

Dec 21, 2017

TARIS Biomedical Announces $25M Series B Financing

Dec 14, 2017

Relay Therapeutics Secures $63 Million in Series B Financing

Dec 13, 2017

Pionyr Immunotherapeutics Completes $62 Million Series B Financing to Advance Antibody-based Therapeutics Targeting the Tumor Microenvironment

Dec 7, 2017

Metacrine Completes Series B Financing to Advance Best-in-Class FXR Program into Clinical Development

Nov 30, 2017

Semma Therapeutics Raises $114 Million Series B Financing

Nov 27, 2017

Medeor Therapeutics Raises $57 Million In Series B Financing

Nov 16, 2017

RDD Pharma Raises $9.5M in Series B Funding to Fuel Global Development

Nov 7, 2017

EOC Pharma Completed Series B Financing From Leading Global Investors

Nov 6, 2017

NousCom Raises €42 Million Series B Financing

Oct 18, 2017

Blade Therapeutics Announces Selection of a Clinical Development Candidate and Funding of the Second Tranche for its Series B Financing

Oct 10, 2017

Azura Ophthalmics Receives $16 Million in Series B Funding to Develop Treatment for Leading Cause of Dry Eye Disease

Oct 6, 2017

PanOptica Secures $11 Million to Advance Clinical Development of PAN-90806 – a Novel, Topical Anti-VEGF Eye Drop

Oct 4, 2017

OMEICOS Secures Extension of Series B Financing Round to Expand its Technology into Ophthalmology

Sep 26, 2017

DiscGenics Raises $14 Million in Series B Financing

Sep 20, 2017

XW Labs secures over $17M Series B financing led by Elements Capital and WI Harper

Sep 11, 2017

Amphivena Announces New Key Leadership and Advisors

Aug 17, 2017

Atreca Completes Oversubscribed $35 Million Series B Financing to Advance Novel Cancer Immunotherapies

Aug 8, 2017

Hangzhou Just Biotherapeutics, Ltd. Secures Closing of Series B Financing

Jul 31, 2017

PellePharm Announces Topline Results from Phase 2 Study of Topical Patidegib in Gorlin Syndrome Basal Cell Carcinomas and Third Closing of a $20 Million Series B Financing

Jul 25, 2017

VenatoRx Pharmaceuticals Raises $42 Million Series B

Jun 15, 2017

Checkmate Pharmaceuticals Secures $27 Million Series B Preferred Financing and Appoints Karen Brennan as Chief Operating Officer

Jun 1, 2017

Bicycle Therapeutics Closes £40 Million ($52 Million) in Series B Financing to Advance Clinical Pipeline

May 30, 2017

InventisBio Raises USD19 Million in Series B Financing Led by OrbiMed

May 30, 2017

Evolve BioSystems Completes $20 Million Series B Financing

May 22, 2017

Symic Bio Secures $30 Million Series B Financing and Provides SB-030 Program Update

May 4, 2017

NantKwest and Viracta Therapeutics Announce Series B Financing and Immunotherapy Partnership

Apr 18, 2017

Bonti Raises $11.7 Million in an Oversubscribed Series B Financing to Advance Development of Lead Product EB-001

Mar 22, 2017

BioClin Therapeutics, Inc., Raises $30 Million in Series B Financing Led by Sofinnova Ventures and Ysios Capital

Mar 20, 2017

Pulmocide Limited: Pulmocide Raises $30 Million in Series B Financing

Mar 7, 2017

ImmunoMet Therapeutics Raises $5.0 million in a Series B Financing

Mar 1, 2017

OMEICOS Announces First Closing of €8.3 Million Series B Financing Round and the Initiation of Phase 1 Clinical Trial

Feb 22, 2017

PMV Pharma Secures $74 Million in Series B Financing for Cancer Drugs Targeting p53

Jan 27, 2017

Biscayne Announces Formation of Biscayne Neurotherapeutics and Completion of Series B Financing

Jan 10, 2017

Adynxx Announces Closing of Series B Financing

Jan 9, 2017

Ascentage Pharma Announces Series B Financing of RMB 500 Million to Advance Its Apoptosis-Targeted Novel Therapeutics

Jan 6, 2017

SiteOne Therapeutics Announces Research and Development Agreement With Amgen to Advance Portfolio of Highly Selective, Potent Inhibitors of NaV1.7 for Acute and Chronic Pain

Jan 5, 2017

Avidity Biosciences Raises $16 Million in Series B Financing to Advance Antibody-siRNA Conjugate Platform

Jan 5, 2017

NeRRe Therapeutics Raises £23 Million in Oversubscribed Series B Financing Round

Jan 5, 2017

Neurelis Announces Finalization Of Series B Financing

Dec 14, 2016

amcure Raises €6 Million in Series B Financing and Expands Advisory Board

Nov 2, 2016

Turnstone Biologics Raises $41.4 Million Series B Financing

Nov 2, 2016

Versant Ventures Portfolio Company Turnstone Biologics Completes CAD$55.3 Million Series B

Sep 8, 2016

Chrono Therapeutics Raises $47.6 Million in Series B Financing to Advance its Clinical Platform for Personalized Drug Therapy

Aug 8, 2016

Cleave Biosciences Raises $37 Million Series B Financing

Jul 13, 2016

Second Genome Appoints Glenn Nedwin, Ph.D., as Chief Executive Officer

Jun 23, 2016

Annexon Biosciences Closes $44 Million Series B Financing

Jun 16, 2016

Blade Therapeutics Raises $45 Million Series B Financing with Unparalleled Syndicate of VCs and Strategic Pharma Investors

Jun 15, 2016

Allecra Therapeutics Announces €22 Million Series B Financing

Jun 15, 2016

Rgenix Announces $33 Million Series B Financing to Develop First-in-Class Cancer Therapeutics

May 26, 2016

FLX Bio Announces $50 Million Series B Financing

May 16, 2016

Caribou Biosciences Raises $30 Million in Series B Funding

May 2, 2016

Graybug Vision Announces $44.5 Million Series B Financing

May 2, 2016

Graybug Vision Announces $44.5 Million Series B Financing

Apr 20, 2016

Second Genome Secures $42.6 Million in Series B Financing Led by Pfizer Venture Investments and Roche Venture Fund

Apr 8, 2016

MedDay Secures €34 Million ($38.5M) New Funding

Mar 10, 2016

Aspyrian Therapeutics Inc. closes a $40M Series B financing to advance the precision targeted cancer therapy, RM-1929, to late stage clinical development in recurrent head and neck cancer and other cancer areas.

Feb 22, 2016

IMPACT Therapeutics, Inc. Announces Completion of around $10 Million Series B Financing

Feb 19, 2016

eFFECTOR Therapeutics Increases its Series B Financing Round to $56M

Feb 9, 2016

Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million

Jan 28, 2016

Adagene Raises $28 Million in Series B Funding

Jan 26, 2016

Codiak BioSciences Closes $61 Million Series B Financing

Jan 25, 2016

CARsgen Therapeutics Completes $30 Million Series B Financing

Dec 22, 2015

eFFECTOR Therapeutics Raises $40 Million Series B Financing

Dec 18, 2015

Navitor Pharmaceuticals Announces $33 Million Series B Financing

Dec 15, 2015

KAHR Medical Reports Raising $12M at First Closing of Its Series B Private Equity Financing

Dec 2, 2015

ORIC Pharmaceuticals Announces $53 Million Series B Financing to Support Discovery and Development of Novel Therapies for Treatment-Resistant Cancers

Dec 1, 2015

Velicept Therapeutics, Inc. Raises $21 Million in Series B Financing

Nov 11, 2015

Amplyx Pharmaceuticals Secures $40.5 Million in Series B Financing

Oct 20, 2015

Humacyte Raises $150 Million Series B Financing

Sep 22, 2015

Artax Biopharma Funded to Clinically Develop Breakthrough Oral Therapies for Autoimmune Diseases

Sep 8, 2015

Cognition Therapeutics Completes Oversubscribed $12 Million Series B Financing

Jun 15, 2015

Milestone Pharmaceuticals Closes US$17 Million Series B Financing to Complete Phase 2 Clinical Studies for MSP-2017

Apr 7, 2015

MicroBiome Therapeutics Reports Advances In Three Microbiome Modulator Programs As It Launches Series B Financing

Mar 18, 2015

Nimbus Therapeutics Raises $43 Million in Series B Financing

Mar 5, 2015

Aura Biosciences Closes $21M Series B Financing

Feb 9, 2015

Vaxxas Raises A$25 Million [US$20 Million] in Series B Venture Financing to Accelerate Commercialization of Novel Vaccine Platform

Jan 6, 2015

EnGeneIC Completes $10 Million Series B Financing Led by U.S. Institutional Investor

Dec 22, 2014

ImmusanT Raises $12 Million in Series B Financing

Nov 25, 2014

Cell Medica Announces £50 Million Series B Round to Advance Cancer Program

Nov 6, 2014

Trevi Therapeutics Announces Second Closing of $26 Million Series B Financing for Development of Nalbuphine ER

Oct 14, 2014

DNAtrix Completes $20 Million Series B Financing

Oct 2, 2014

Visterra Closes $30 Million Series B Financing to Advance Pipeline of Multiple Products for Infectious Diseases

Sep 10, 2014

Avelas Biosciences Extends Series B Financing to $7.4 Million to Support Clinical Development of Real-Time Cancer Visualization Technology

Aug 28, 2014

OncoPep Raises $6.9 Million Series B Financing to Advance Novel Cancer Vaccines and Expands Phase 1/2a Clinical Trial

Aug 4, 2014

Rebiotix Inc. Receives $25M for Series B Funding

Jun 4, 2014

Trevi Therapeutics Announces $25 Million Series B Financing Led by TPG Biotech for Development of Nalbuphine ER

Jun 4, 2014

Complexa, Inc. Completes $13 Million Series B Financing to Further Advance Clinical Development of CXA-10

Jan 21, 2014

Promentis Pharmaceuticals Raises Nearly $3 Million in Series B Financing

Jan 9, 2014

Avelas Biosciences Closes $6.85 Million in Series B Financing to Advance Real-Time Cancer Visualization Technology to Clinical Proof-of-Concept

Dec 3, 2013

Blaze Bioscience Raises $9 million in Series B Financing

Nov 4, 2013

Hookipa Biotech Closes €20 Million ($27.5 Million) in Series B Financing

Aug 28, 2013

Rani Therapeutics™ Secures Series B Funding; Round Led by Google Ventures

Aug 22, 2013

MicuRx Completes $25 Million Series B Financing

Jul 22, 2013

Alcresta Secures $10 Million Series B Financing, Prepares for 2014 Commercial Launch of Novel Point-of-Care Nutritional Products

Jun 26, 2013

Complix Raises €12 Million (US$15.5 million) in Series B Round

Oct 8, 2012

Gliknik Raises $4.9 Million In Series B Financing Led By Baxter Ventures

Sep 6, 2012

Karus Therapeutics Secures Series B Financing from a Syndicate of Leading VC Investors

Jul 9, 2012

PsiOxus Therapeutics Secures £22 Million ($34 Million) in Series B Financing to Drive Clinical Development for Oncolytic Vaccine

Sep 8, 2011

Theraclone Sciences Secures $10.6 Million in Series B Extension Financing

Mar 15, 2010

NGM Biopharmaceuticals Raises $51 Million in Series B Financing and Appoints New Board Member